$10M from Tam Foundation

Gift will support precision health and Prechter Bipolar Research Program

Author | Kara Gavin

Top photo: Judith Tam, president of the Richard Tam Foundation, with Sachin Kheterpal, M.D., M.B.A., co-director of Precision Health at U-M. 

Nearly 6 million Americans have bipolar disorder, and as many as one in five of those may die by suicide. Finding a treatment strategy, even with the help of an experienced treatment team, can be difficult. A new gift aims to bring more precision to the process. It will expand and harness the power of massive data from U-M's Heinz C. Prechter Bipolar Research Program and allow researchers to use advanced tools created for Precision Health at U-M. 

The $5.8 million gift brings the Richard Tam Foundation's total giving to U-M for bipolar research to $10 million. Support includes $500,000 for Precision Health at U-M, its first major gift. 

Judith Tam, president of the Richard Tam Foundation, says the combination of U-M's strength in studying bipolar disorder and related conditions, and its investment in precision health, inspired the gift. "Precision health could help doctors figure out the right medicine to give to a particular patient, much more quickly, and could expand their toolbox through new discoveries," she says. "We've got brilliant people here, and I've seen the passion in their eyes when they talk about their research. They're not just doing their work and going home. They are on fire." 

"Precision Health is developing unprecedented insights into human health and disease, and I'm grateful to Judith Tam for her generous support," says U-M president Mark Schlissel, M.D., Ph.D. "This gift from the Richard Tam Foundation will enhance our bipolar disorder research by taking advantage of the genetic and lab test data platform assembled by Precision Health at U-M, resulting in improved care for millions of patients." 

Sachin Kheterpal, M.D., M.B.A., co-director of U-M Precision Health, praises the Richard Tam Foundation's position as a pioneer in giving to the new U-M initiative. "It's a very generous gift that is hopefully a model for future gifts, where we're able to demonstrate the value of researching individual diseases, marrying that research data with the Precision Health platforms we're building, and thereby increasing the potential for hundreds of researchers to benefit from the overall impact," he says. The gift will create a Tam Precision Health & Bipolar Collaboration Fund within Precision Health. 

Precision Health, launched in early 2018, offers researchers across U-M access to genetic and clinical data, as well as the tools, expertise, training, and funding they need to use them to advance their research. 

"We absolutely need to leverage our Precision Health platform to advance and support the pace of discovery research," says Marschall S. Runge, M.D., Ph.D executive vice president for medical affairs at U-M, CEO of Michigan Medicine, and dean of the Medical School. "We are highly committed to collecting more robust bipolar research data, as well as information on other therapeutic treatments that would benefit from a very personalized approach." 

In addition to supporting Precision Health-related work, the new gift will continue support for bipolar disorder research projects at the Prechter Program. It will also create a professorship in the Department of Psychiatry, with the proposed name of the Richard Tam Professorship in Translational Bipolar Research. This will allow the recruitment of another top bipolar researcher to U-M. 

The Richard Tam Foundation issued a challenge to others interested in moving bipolar research forward at U-M, offering to match bequests to the Prechter Bipolar Research Program documented by June 30, 2020. Judith Tam (pictured) hopes that the new gift and bequest challenge will inspire more giving by those who have seen the impact of bipolar disorder or other diseases on those they love. 

Melvin McInnis, M.D., scientific director of the Heinz C. Prechter Bipolar Research Program, says, "The work that we're doing with Precision Health is absolutely fundamental and transformational in terms of the future of medicine, the future of mental health research, and the future of our understanding of various human illnesses." 


More Articles About: Philanthropy bipolar disorder Research Data precision health gift Tam Prechter
Featured News & Stories Toddler Martina smiling.
Philanthropy News
Rallying Together to Support Childhood Cancer Awareness and Research
September is National Childhood Cancer Awareness Month, a time to recognize the impact of pediatric cancer and highlight the importance of research and patient programs.
bottle cap red
Health Lab
Bipolar disorder and alcohol: It’s not as simple as 'self-medication'
People with bipolar disorder have a high risk of alcohol use issues, which have been seen as “self medication,” but a study shows that changes in drinking predict worse symptoms.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Addressing health care inequality
An expert on racial and ethnic differences in health care and health outcomes offers recommendations as part of a national committee.
Ophthalmologist Adam Jacobson, M.D., examines a young patient.
Philanthropy News
Gift Aims to Save Children’s Sight
Timothy and Laurie Wadhams’s gift to the W.K. Kellogg Eye Center establishing the Wadhams Family Center for Childrens Vision will advance congenital eye disease research.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month. On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.